Assessing the Roles of Molecular Markers of Antimalarial Drug Resistance and the Host Pharmacogenetics in Drug-Resistant Malaria
Malaria caused by the Plasmodium parasites is a major public health concern in malaria-endemic regions with P. falciparum causing the most severe form of the disease. The use of antimalarial drugs for the management of the disease proves to be one of the best methods to manage the disease. Unfortuna...
Saved in:
Main Authors: | Peter Hodoameda, Nancy Odurowah Duah-Quashie, Neils Ben Quashie |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Journal of Tropical Medicine |
Online Access: | http://dx.doi.org/10.1155/2022/3492696 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacogenetics of Oral Antidiabetic Drugs
by: Matthijs L. Becker, et al.
Published: (2013-01-01) -
Chemotherapy of Drug-Resistant Malaria
by: Kevin C Kain
Published: (1996-01-01) -
A reaction-diffusion system modeling the spread of resistance to an antimalarial drug
by: Nicolas Bacaër, et al.
Published: (2005-02-01) -
Pharmacogenetic markers of colorectal cancer treatment. New approaches for cytostatic drugs efficacy estimation
by: N. B. Zakharzhevskaya, et al.
Published: (2015-12-01) -
Serine Proteases of Malaria Parasite Plasmodium falciparum: Potential as Antimalarial Drug Targets
by: Asrar Alam
Published: (2014-01-01)